Biocon bets big on new class of weight-loss drugs
Company aims to ramp up portfolio as key drugs—that were actually formulated to treat diabetes—go off patent
Company aims to ramp up portfolio as key drugs—that were actually formulated to treat diabetes—go off patent Company aims to ramp up portfolio as key drugs—that were actually formulated to treat diabetes—go off patent Moneycontrol Latest News Read More
Company aims to ramp up portfolio as key drugs—that were actually formulated to treat diabetes—go off patent
Top Nifty gainers and losers at mid-day: Cipla and Divi#39;s gain, HCL, TCS sink
The market was trading flat at noon on mixed Asian cues with IT stocks under selling pressure once again, About 1,688 shares advanced, 1,391 declined, and 105 were unchanged.
The market was trading flat at noon on mixed Asian cues with IT stocks under selling pressure once again, About 1,688 shares advanced, 1,391 declined, and 105 were unchanged. The market was trading flat at noon on mixed Asian cues with IT stocks under selling pressure once again, About 1,688 shares advanced, 1,391 declined, and 105 were unchanged. Moneycontrol Latest News Read More
The market was trading flat at noon on mixed Asian cues with IT stocks under selling pressure once again, About 1,688 shares advanced, 1,391 declined, and 105 were unchanged.
Regulator begins major enforcement drive on poor drug-making practices
These enforcement actions are a part of risk-based inspection to ensure Good Manufacturing Practices (GMP) norms are met
These enforcement actions are a part of risk-based inspection to ensure Good Manufacturing Practices (GMP) norms are met These enforcement actions are a part of risk-based inspection to ensure Good Manufacturing Practices (GMP) norms are met Moneycontrol Latest News Read More
These enforcement actions are a part of risk-based inspection to ensure Good Manufacturing Practices (GMP) norms are met
हिन्दी 
English